Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2012

Open Access 01-12-2012 | Study protocol

Study protocol: a dissemination trial of computerized psychological treatment for depression and alcohol/other drug use comorbidity in an Australian clinical service

Authors: Frances J Kay-Lambkin, Amanda L Baker, Alison Healey, Samantha Wolfe, Aaron Simpson, Michelle Brooks, Jenny Bowman, Steven Childs

Published in: BMC Psychiatry | Issue 1/2012

Login to get access

Abstract

Background

The rise of the internet and related technologies has significant implications for the treatment of complex health problems, including the combination of depression and alcohol/other drug (AOD) misuse. To date, no research exists to test the real world uptake of internet and computer-delivered treatment programs in clinical practice. This study is important, as it is the first to examine the adoption of the SHADE treatment program, a DVD-based psychological treatment for depression and AOD use comorbidity, by clinicians working in a publicly-funded AOD clinical service. The study protocol that follows describes the methodology of this dissemination trial.

Methods/design

19 clinicians within an AOD service on the Central Coast of New South Wales, Australia, will be recruited to the trial. Consenting clinicians will participate in a baseline focus group discussion designed to explore their experiences and perceived barriers to adopting innovation in their clinical practice. Computer comfort and openness to innovation will also be assessed. Throughout the trial, current, new and wait-list clients will be referred to the research program via the clinical service, which will involve clients completing a baseline and 15-week follow-up clinical assessment with independent research assistants, comprising a range of mental health and AOD measures. Clinicians will also complete session checklists following each clinical session with a client, outlining the extent to which the SHADE computer program was used. Therapeutic alliance will be measured at intake and discharge from both the clinician and client perspectives.

Discussion

This study will provide comprehensive data on the factors associated with the adoption of an innovative, computer-delivered evidence-based treatment program, SHADE, by clinicians working in an AOD service. The results will contribute to the development of a model of dissemination of SHADE, which could be applied to a range of technological innovations.

Clinical trials registry

Australian Clinical Trial Registration Number: ACTRN12611000382976.
Literature
1.
WHO: The Global Burden of Disease: 2004 update. 2008, Geneva: World Health Organisation (WHO) Press
2.
APA: Practice guideline for the treatment of patients with major depressive disorder (Revision). Am J Psychiatry. 2000, 157: 1-45.CrossRef
3.
APA: Practice guideline for the treatment of patients with substance use disorders: Alcohol, cocaine, opiods. Am J Psychiatry. 1995, 152: 1-59.CrossRef
4.
ABS: National Survey of Mental Health and Wellbeing: Summary of Results, 2007. 2008, Canberra: Australian Bureau of Statistics, Publication No. 4326.0
5.
Tylee A: Major depressive disorder (MDD) fromthe patient’s perspective: overcoming barriers to appropriate care. Int J Psychiatry Clin Pract. 2001, 5: s37-s42. 10.1080/13651500152048432.CrossRef
6.
ABS: National Survey of Mental Health and Wellbeing: Summary of Results. 2007, Canberra, Australia: Australian Bureau of Statistics
7.
Kay-Lambkin FJ, Baker A, Lewin T: The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug Alcohol Rev. 2004, 23: 407-424. 10.1080/09595230412331324536.CrossRefPubMed
8.
Helmus TC, Downey KK, Wang LM, Rhodes GL, Schuster CR: The relationship between self-reported cocaine withdrawal symptoms and history of depression. Addict Behav. 2001, 26: 461-467. 10.1016/S0306-4603(00)00105-2.CrossRefPubMed
9.
Kavanagh DJ, Mueser K, Baker A: Management of co-morbidity. Co-morbid Mental Disorders and Substance Use Disorders: Epidemiology, Prevention and Treatment. Edited by: Teesson M. 2003, Canberra: Commonwealth of Australia, 78-107.
10.
Brown CH, Ten-Have TR, Jo B, Dagne G, Wyman PA, Muthen B, Gibbons RD: Adaptive Designs for Randomized Trials in Public Health. Annu Rev Public Health. 2009, 30: 1-25. 10.1146/annurev.publhealth.031308.100223.CrossRefPubMedPubMedCentral
11.
Kaltenthaler E, Parry G, Beverley C, Ferriter M: Computerised cognitive-behavioural therapy for depression: systematic review. Br J Psychiatry. 2008, 193: 181-184. 10.1192/bjp.bp.106.025981.CrossRefPubMed
12.
Christensen H, Griffiths KM, Korten A: Web-based Cognitive Behavior Therapy: Analysis of Site Usage and Changes in Depression and Anxiety Scores. J Med Internet Res. 2002, 4: e3-10.2196/jmir.4.1.e3.CrossRefPubMedPubMedCentral
13.
Bridgette M, Bewick A, Trusler A, Barkham C, Hill AJ, Cahill J, Mulhern B: The effectiveness of web-based interventions designed to decrease alcohol consumption — A systematic review. Prev Med. 2008, 47: 17-26. 10.1016/j.ypmed.2008.01.005.CrossRef
14.
15.
Proudfoot JG: Computer-based treatment for anxiety and depression: Is it feasible? Is it effective?. Neurosci Biobehav Rev. 2004, 28: 353-363. 10.1016/j.neubiorev.2004.03.008.CrossRefPubMed
16.
Kay-Lambkin FJ, Baker A, Lewin TJ, Carr VJ: Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction. 2009, 104: 378-388. 10.1111/j.1360-0443.2008.02444.x.CrossRefPubMed
17.
Wangberg SC, Gammon D, Spitznogle K: In the eyes of the beholder: exploring psychologists’ attitudes towards and use of e-therapy in Norway. Cyberpsychol Behav. 2007, 10: 418-423. 10.1089/cpb.2006.9937.CrossRefPubMed
18.
Akers A: The motivation and other characteristics of clients seeking treatment from an outpatient “Cannabis Clinic”. 2007, Psychology: University of Newcastle
19.
20.
Kay-Lambkin FJ, Baker A, Lewin TJ, Carr VJ: Acceptability of a clinician-assisted computerized psychological intervention for comorbid mental health and substance use problems: Treatment adherence data from a randomized controlled trial. J Med Internet Res. 2011, 13: e11p11-e11-p11.CrossRef
21.
Hurt HT, Joseph K, Cook CD: Scales for the measurement of innovativeness. Human Communication Research. 1977, 4: 58-65. 10.1111/j.1468-2958.1977.tb00597.x.CrossRef
22.
Maurer MM, Simonson MR: The reduction of computer anxiety: its relation to relaxation training, previous computer coursework, achievement, and need for cognition. Journal of Research on Computing in Education. 1994, 26: 205-CrossRef
23.
Agnew-Davies R, Stiles WB, Hardy GE, Barkham M, Shapiro DA: Alliance structure assessed by the Agnew Relationship Measure. British Journal of Clinical Psychiatry. 1998, 37: 155-172. 10.1111/j.2044-8260.1998.tb01291.x.CrossRef
24.
Darke S, Hall W, Wodak A, Heather N, Ward J: Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992, 87: 733-742. 10.1111/j.1360-0443.1992.tb02719.x.CrossRefPubMed
25.
Lovibond SH, Lovibond PF: Manual for the depression anxiety stress scales. 1995, Psychology Foundation, Sydney
26.
APA: Global assessment of functioning scale. Diagnostic and Statistical Manual. 1994, Washington: American Psychiatric Association, Fourth Edition
27.
Neff KD: Development and validation of a scale to measure self-compassion. Self and Identity. 2003, 2: 223-250. 10.1080/15298860309027.CrossRef
28.
Bennett GG, Glasgow RE: The delivery of public health interventions via the Internet: Actualizing their potential. Annu Rev Public Health. 2009, 30: 273-292. 10.1146/annurev.publhealth.031308.100235.CrossRefPubMed
29.
Glasgow R, McKay H, Piette J, Reynolds K: The RE-AIM framework for evaluating interventions: What can it tell us about approaches to chronic illness management?. Patient Education and Counselling. 2001, 44: 119-127. 10.1016/S0738-3991(00)00186-5.CrossRef
Metadata
Title
Study protocol: a dissemination trial of computerized psychological treatment for depression and alcohol/other drug use comorbidity in an Australian clinical service
Authors
Frances J Kay-Lambkin
Amanda L Baker
Alison Healey
Samantha Wolfe
Aaron Simpson
Michelle Brooks
Jenny Bowman
Steven Childs
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2012
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-12-77

Other articles of this Issue 1/2012

BMC Psychiatry 1/2012 Go to the issue

Research article

Prevalence rate, predictors and long-term course of probable posttraumatic stress disorder after major trauma: a prospective cohort study

Research article

Executive attention impairment in first-episode schizophrenia

Study protocol

Tavistock Adult Depression Study (TADS): a randomised controlled trial of psychoanalytic psychotherapy for treatment-resistant/treatment-refractory forms of depression

Research article

The characteristics of serious suicide attempters in Japanese adolescents- comparison study between adolescents and adults

Research article

Prevention of anxiety disorders in primary care: A feasibility study

Research article

A rapid screening tool for psychological distress in children 3–6years old: results of a validation study